Akter, S., Hossain, M. T., Sarkar, A. P., Sadikuzzaman, M., Sarkar, B. K., Saha, P., & Kundu, S. K. (2022). Development and validation of HPLC method for estimation of sitagliptin in the tablet dosage form.
2. Punagoti, R. A., & Mourya, R. (2021). Development and validation of new RP-HPLC method for the quantitative estimation of sitagliptin phosphate in bulk and tablet dosage form. Journal of Advanced Scientific Research, 12(03 Suppl 2), 301-305.
3. Bergman, A. J., Stevens, C., Zhou, Y., Yi, B., Laethem, M., De Smet, M., Snyder, K., Hilliard, D., Tanaka, W., Zeng, W., Tanen, M., Wang, A. Q., Chen, L., Winchell, G., Davies, M. J., Ramael, S., Wagner, J. A., & Herman, G. A. (2006). Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers. Clinical therapeutics, 28(1), 55–72. https://doi.org/10.1016/j.clinthera.2006.01.015
4. Lavanya, R., & Yunoos, M. (2013). Development and validation of RP-HPLC method for the estimation of sitagliptin phosphate in bulk and its tablet dosage form. Journal of Advanced Pharmacy Education and Research, 3(4-2013), 475-479.
5. Qassas, M. K., Ameral-mardini, M., & Ghazal, H. (2015). A validated HPLC stability indicating method for the determination of sitagliptin in bulk drug substance and tablets. Int. J. Pharm. Sci. Rev. Res, 32(1), 33-194.
6. Krishnan, B., & Mishra, K. (2020). Quality by Design based Development and Validation of RP-HPLC Method for Simultaneous Estimation of Sitagliptin and Metformin in Bulk and Pharmaceutical Dosage Forms. International Journal of Pharmaceutical Investigation, 10(4).
7. Ramalingam, P., Bhaskar, V. U., Reddy, Y. P., & Kumar, K. V. (2014). Stability-indicating RP-HPLC method for the simultaneous determination of sitagliptin and simvastatin in tablets. Indian Journal of Pharmaceutical Sciences, 76(5), 407.
8. Zhou, T. Y. (2011). method for the Quantitative determination of sitagliptin in rat plasma. Journal of Chinese Pharmaceutical Sciences, 20, 63-69.
9. Rubina, R., & Gopal, R. (2015). Development and Validation of Spectrophotometric Method for Simultaneous Estimation of Gliclazide and Sitagliptin Phosphate Monohydrate in Bulk and Pharmaceutical Dosage Form. International Journal of Pharmacy and Pharmaceutical Sciences, 7(6), 372-376.
10. Sangshetti, J. N., Deshpande, M., Zaheer, Z., Shinde, D. B., & Arote, R. (2017). Quality by design approach: Regulatory need. Arabian Journal of chemistry, 10, S3412-S3425.
11. Gunda, R. K., Kumar, J. S., Babu, C. A., & Anjaneyulu, M. V. (2015). Formulation Development And Evaluation Of Lamotrigine Sustained Release Tablets Using 3 2 Factorial Design. Cellulose, 4, 5.
12. Kumar, L., Reddy, M. S., Managuli, R. S., & Pai, G. (2015). Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles. Saudi Pharmaceutical Journal, 23(5), 549-555.
13. Ravichandran, V., Shalini, S., Sundram, K. M., & Harish, R. (2010). Validation of analytical methods–strategies & importance. International Journal of Pharmacy and Pharmaceutical Sciences, 2(3), 18-22.
14. Yahya, B. A., Bawazir, A. S., Sangshetti, J. N., Baig, S. S., & Shaikh, S. S. (2021). QbD-based development and validation of an efficient RPHPLC method for estimation of abiraterone acetate in bulk, tablet, and in-house-developed nano-formulation. Analytical chemistry letters, 11(1), 112-130.
15. Sharma, S., Goyal, S., & Chauhan, K. (2018). A review on analytical method development and validation. International Journal of Applied Pharmaceutics, 10(6), 8-15.